-logo.jpg "AmerisourceBergen logo")
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone610-727-7000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$167.94 billion
Profitability
Miscellaneous
Employees21,000
OptionableOptionable
AmerisourceBergen (NYSE:ABC) Frequently Asked Questions
What is AmerisourceBergen's stock symbol?
AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."
How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?
AmerisourceBergen declared a quarterly dividend on Tuesday, February 5th. Stockholders of record on Tuesday, February 19th will be given a dividend of $0.40 per share on Monday, March 4th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend is Friday, February 15th. View AmerisourceBergen's Dividend History.
How were AmerisourceBergen's earnings last quarter?
AmerisourceBergen Corp. (NYSE:ABC) announced its quarterly earnings data on Thursday, January, 31st. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.50 by $0.10. The business had revenue of $45.39 billion for the quarter, compared to analysts' expectations of $43.52 billion. AmerisourceBergen had a net margin of 0.69% and a return on equity of 44.53%. View AmerisourceBergen's Earnings History.
When is AmerisourceBergen's next earnings date?
What guidance has AmerisourceBergen issued on next quarter's earnings?
AmerisourceBergen updated its FY19 earnings guidance on Thursday, January, 31st. The company provided EPS guidance of $6.65-6.85 for the period, compared to the Thomson Reuters consensus estimate of $6.76. AmerisourceBergen also updated its FY 2019 guidance to $6.65-6.85 EPS.
What price target have analysts set for ABC?
9 brokers have issued 1-year price objectives for AmerisourceBergen's shares. Their forecasts range from $84.00 to $115.00. On average, they expect AmerisourceBergen's share price to reach $96.00 in the next year. This suggests a possible upside of 10.8% from the stock's current price. View Analyst Price Targets for AmerisourceBergen.
What is the consensus analysts' recommendation for AmerisourceBergen?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AmerisourceBergen.
Has AmerisourceBergen been receiving favorable news coverage?
Media headlines about ABC stock have trended very positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. AmerisourceBergen earned a media sentiment score of 3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term.
Who are some of AmerisourceBergen's key competitors?
Who are AmerisourceBergen's key executives?
AmerisourceBergen's management team includes the folowing people:
- Mr. Steven H. Collis, Chairman, Pres & CEO (Age 58)
- Mr. James F. Cleary Jr., CFO & Exec. VP (Age 56)
- Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 63)
- Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 52)
- Mr. Dale B. Danilewitz, Exec. VP & Chief Information Officer (Age 57)
Who are AmerisourceBergen's major shareholders?
AmerisourceBergen's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.25%), Oregon Public Employees Retirement Fund (1.63%), Victory Capital Management Inc. (1.14%), Beutel Goodman & Co Ltd. (1.07%), Northern Trust Corp (1.01%) and Baupost Group LLC MA (0.95%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Gina Clark, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Institutional Ownership Trends for AmerisourceBergen.
Which major investors are selling AmerisourceBergen stock?
ABC stock was sold by a variety of institutional investors in the last quarter, including Baupost Group LLC MA, Ceredex Value Advisors LLC, Canada Pension Plan Investment Board, Bank of New York Mellon Corp, Bank of America Corp DE, Gotham Asset Management LLC, Allen Investment Management LLC and Ferguson Wellman Capital Management Inc.. Company insiders that have sold AmerisourceBergen company stock in the last year include Dale Danilewitz, Gina Clark, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Robert P Mauch, Steven H Collis and Tim G Guttman. View Insider Buying and Selling for AmerisourceBergen.
Which major investors are buying AmerisourceBergen stock?
ABC stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Victory Capital Management Inc., Boston Partners, Millennium Management LLC, RWC Asset Management LLP, RWC Asset Management LLP, J. L. Bainbridge & Co. Inc. and First Trust Advisors LP. View Insider Buying and Selling for AmerisourceBergen.
How do I buy shares of AmerisourceBergen?
Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AmerisourceBergen's stock price today?
One share of ABC stock can currently be purchased for approximately $86.66.
How big of a company is AmerisourceBergen?
AmerisourceBergen has a market capitalization of $18.29 billion and generates $167.94 billion in revenue each year. The company earns $1.66 billion in net income (profit) each year or $6.49 on an earnings per share basis. AmerisourceBergen employs 21,000 workers across the globe.
What is AmerisourceBergen's official website?
How can I contact AmerisourceBergen?
AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]
MarketBeat Community Rating for AmerisourceBergen (NYSE ABC)
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
